Analysis of MMP2 promoter polymorphisms in childhood obesity
© Morgan et al; licensee BioMed Central Ltd. 2011
Received: 9 February 2011
Accepted: 21 July 2011
Published: 21 July 2011
Several lines of evidence suggest a possible functional role of Matrix metalloproteinase -2 (MMP-2) in obesity. The aim of this study was to evaluate the role of MMP-2 promoter polymorphisms in percentage body fat (PBF) as a measure of childhood obesity in a New Zealand population.
546 samples from the Auckland Birthweight Collaborative (ABC) study were genotyped for the three MMP-2 promoter SNPs -1306 C/T (rs243865), -1575G/A (rs243866) and -790 T/G (rs243864) using the Sequenom genotyping platform. The results demonstrated that an MMP-2 promoter haplotype is associated with PBF in New Zealand 7 year old children.
We have previously determined that environmental factors are associated with differences in PBF in this study group, and now we have demonstrated a possible genetic contribution.
Keywordschildhood obesity percentage body fat matrix metalloproteinase-2 genetic association
Obesity is reaching epidemic proportions worldwide and is now occurring at younger ages. In New Zealand, one in twelve youngsters aged 2 to 14 years are considered to be obese and one in five are classified as overweight (A Portrait of Health, 2006/07 New Zealand Health Survey).
Obese children are at increased risk of a number of health problems including diabetes, sleep problems, joint problems, early puberty or menarche, asthma and other respiratory problems . Obesity often persists into adulthood and is associated with increased morbidity and mortality [2, 3].
Body mass index (BMI) is the most common method used to determine obesity. However, although BMI may facilitate an adult obesity diagnosis, using this method to diagnose obesity in children may yield more ambiguous results, as BMI is a marker of relative weight and doesn't directly measure body fat . Measuring percentage body fat (PBF) may be a more effective method of diagnosing obesity in children.
Childhood obesity is thought to be the result of an interplay between many genetic and environmental factors. We have previously investigated environmental factors in the Auckland Birthweight Collaborative (ABC) study, and found maternal overweight/obesity, maternal age, female gender, sedentary activity time and hours of television viewing to be independently associated with PBF in 7 year old children . We are now interested in identifying possible genetic factors.
Several lines of evidence suggest a possible functional role of Matrix metalloproteinase -2 (MMP-2) in obesity. The main role of MMP-2 is in the degradation of type IV collagen, the major structural component of basement membranes. However, the enzyme also has activity toward a spectrum of functional molecules including growth factor-binding proteins and growth factor receptors, which are known to be involved in obesity. For example, MMP-2 can cleave insulin-like growth factor-binding proteins and release insulin-like growth factors . It has also been suggested that MMP-2 plays an important role in adipose tissue development [7–10]. Furthermore, tissue degradation by MMP-2 is pivotal to inflammation , and obesity is associated with low grade inflammation.
We undertook an association analysis of 3 functional polymorphisms in the promoter of the MMP-2 gene (-1306C/T, -1575G/A and -790T/G), to investigate the possible role for MMP-2 as a genetic risk factor for obesity (in terms of increased PBF) in the ABC study.
The -1306 C/T (rs243865) polymorphism is located in the CCACC box of the Sp1-binding site and displays a strikingly lower promoter activity with the T allele . The -1575G/A (rs243866) variant is located immediately 5' to a half-palindromic potential oestrogen receptor binding site and the G allele functions as an enhancer . The -790 T/G (rs243864) SNP is located in the inverted GATA-1 element (CTATCT) in the promoter region. Three important transcription factors (GKLF-gut enriched Krueppel-like factor, S8, and Evil-ectopic viral integration site 1 encoded factor) may bind with the T allele but not with the G allele .
The ABC study was designed as a case-control study to determine risk factors for small for gestational age (SGA) infants and has been described in detail previously . Data have been collected at birth, 1, 3.5, 7 and most recently 11 years of age. The original sample at birth resulted in a sample of 1714 subjects, of which 871 mothers were identified in the obstetric data to be of European ethnicity. At the age of 1 and 3.5 follow up of non-European ethnicities was poor resulting in a lack of ability to generalise the results from these children to their particular populations. As a result follow-up from the age of 7 has only been carried out on those children whose mothers were identified as European ethnicity at birth.
Percentage body fat (PBF) at age 7 years was the outcome measure analysed in this paper. This was measured using bioelectrical impedance analysis (BIA). This allows calculation of fat free mass which was calculated according to the formula of Schaeffer et al  and consequently percentage body fat.
At 11 years 546 participants consented to collection of peripheral blood (n = 397) or a buccal swab (n = 149) for DNA extraction and genotyping.
DNA was extracted from the blood/buccal samples using Qiagen's DNA extraction kit and following the manufacturer's instructions. Genotyping was performed with the MassARRAY and iPlex systems of the Sequenom genotyping platform (Sequenom, San Diego, CA), which uses the MALDI-TOF primer extension assay [17, 18], according to manufacturers' recommendations. The SNPs were in a multiplex with SNPs from a different study that used the same samples. Assays were optimized in 24 samples consisting of 20 reference Centre d'Etude du Polymorphisme Humain (CEPH) samples and 4 blanks. All sample plates contained cases, controls, blanks, CEPH and duplicate samples. Quality control measures included independent double genotyping, blind to sample identity and blind to the other caller, and comparison of our CEPH genotypes to those in the HapMap http://www.hapmap.org.
SNPs were tested for deviation from Hardy-Weinberg equilibrium (HWE) using a chi-square goodness-of-fit test.
A Generalised linear model (GLM) was used to test the linearity of genotype-phenotype relationship for quantitative traits. For linearity of the genotype-phenotype relationship for quantitative traits, each SNP was coded 0, 1, and 2 for each tested allele [19, 20]. For example, G/G, G/T, and T/T were coded as 0, 1, and 2 for the T allele for rs243864. All analyses were controlled for SGA status due to the disproportionate sample of SGA and AGA at birth (phase 1). Multivariable analyses also controlled for environmental factors previously shown to be independently related in this dataset to PBF namely sex of the child, maternal body mass index, maternal age at the birth of the child, hours of television watched per day, and the amount of time spent in sedentary activities .
To determine LD (linkage disequilibrium) between the SNPs we uploaded our data into haploview . Haplotype blocks were defined using the default algorithm which uses confidence intervals . Haplotype analysis was carried out using HAPLO.SCORE in R to test for association of the haplotypes with PBF.
Statistical analyses were carried out using R  and SAS (V9.1 SAS Institute., Cary, NC, USA). A p-value less than 0.05 was considered statistically significant.
The study received ethical approval from the Northern Regional Ethics Committee. Signed consent for the study and extraction of DNA was given by the parents of the children and assent also given by the child.
Genotype counts (frequencies) for the MMP2 promoter SNPs in the ABC samples
AA = 31 (0.060)
AG = 191 (0.350)
GG = 305 (0.590)
TT = 34 (0.066)
CT = 179 (0.347)
CC = 303 (0.587)
GG = 33 (0.063)
GT = 185 (0.350)
TT = 310 (0.587)
Effect of MMP2 promoter SNPs on PBF
Estimate (95% CI)
1.32 (0.08 - 2.56)
1.40 (0.16 - 2.64)
1.42 (0.16 - 2.69)
Effect of MMP2 promoter SNPs on PBF after adjustment for confounding factors
Estimate (95% CI)
0.990 (-0.19 - 2.17)
1.144 (-0.03 - 2.31)
1.164 (-0.03 - 2.36)
Haplotype analysis after adjustment for confounding factors
This paper reports for the first time the role of MMP-2 promoter polymorphisms in childhood obesity as measured using PBF. Although we were unable to demonstrate an association for the 3 SNPs individually after correcting for confounding factors, the GTA (rs243864, rs243865, 243866) haplotype was statistically significant. It has previously been suggested that studying haplotypes could be more informative than the study of individual SNPs [24, 25].
Genetic variation in MMP-2 has been previously investigated for association with obesity, in adults from Korea . Whereas we have focussed on promoter SNPs and PBF, Han et al. investigated coding SNPs and looked for association with BMI. They found 2 SNPs (out of the 5 investigated) to be associated with overweight/obesity, and also identified a haplotype as significant. Taken together with our own results, it can be concluded that MMP-2 may be an important susceptibility gene for obesity in both children and adults.
The genetic association we report in the MMP-2 promoter may result from altered MMP expression, as the 3 SNPs investigated are all functional SNPs capable of affecting transcriptional activity. Indeed, associations with MMP-2 circulating levels in mouse models and obese children and adults have been previously reported. High expression of MMP-2 has been demonstrated in adipose tissue of mice with nutritionally induced obesity, as well as in genetically obese mice [9, 10, 27]. Bouloumiè et al.  provided the first evidence that human adipose tissue releases MMP-2. Later two studies by the same group described decreased circulating levels of MMP-2 (and increased levels of MMP-9 and TIMP-1) in obese children [28, 29]. Whilst a study examining obesity in adults demonstrated increased MMP-2 (and MMP-9) levels .
Additional studies are now required to further investigate MMP-2 involvement in the development of obesity. It may be also be worth considering other matrix metalloproteinases.
In conclusion the results presented here demonstrate that an MMP-2 promoter haplotype is associated with PBF in New Zealand 7 year old children. We have previously determined that environmental factors are associated with differences in PBF in the ABC study, and now we have demonstrated a possible genetic contribution.
The initial study was funded by the Health Research Council of New Zealand. The 12 month postal questionnaire was funded by Hawkes Bay Medical Research Foundation. The 3.5 year follow-up study was funded by Child Health Research Foundation, Becroft Foundation and Auckland Medical Research Foundation. The 7 year follow-up study was funded by Child Health Research Foundation. The 11 year follow-up was funded by Child Health Research Foundation and the Heart Foundation. The genetic component of this study was funded by Child Health Research Foundation. We acknowledge the assistance of Gail Gillies, Barbara Rotherham and Helen Nagels for contacting or assessing the participants. We sincerely thank the parents and children for participating in this study. The assessments of the children were conducted mainly in the Starship Children's Research Centre that is supported by the Starship Foundation and Auckland HealthCare Ltd.
EA Mitchell and JMD Thompson are supported by the Child Health Research Foundation. AR Morgan, DY Han and LR Ferguson are supported by Nutrigenomics New Zealand which is collaboration between AgResearch Ltd., Plant & Food Research and The University of Auckland with funding through the Foundation for Research Science and Technology.
- Lee YS: Consequences of childhood obesity. Ann Acad Med Singapore. 2009, 38 (1): 75-77.PubMedGoogle Scholar
- Whitaker RC, Wright JA, Pepe MS, et al: Predicting obesity in young adulthood from childhood and parental obesity. N Engl J Med. 1997, 337: 869-873. 10.1056/NEJM199709253371301.PubMedView ArticleGoogle Scholar
- Micić D: Obesity in children and adolescents--a new epidemic? Consequences in adult life. J Pediatr Endocrinol Metab. 2001, 14 (Suppl 5): 1345-1352.PubMedGoogle Scholar
- Hall DM, Cole TJ: What use is the BMI?. Arch Dis Child. 2006, 91: 283-286. 10.1136/adc.2005.077339.PubMedPubMed CentralView ArticleGoogle Scholar
- Blair NJ, Thompson JMD, Black PN, et al: Risk factors for obesity in 7-year-old European children: the Auckland Birthweight Collaborative Study. Arch Dis Child. 2007, 92 (10): 866-871. 10.1136/adc.2007.116855.PubMedPubMed CentralView ArticleGoogle Scholar
- Sternlicht MD, Werb Z: Matrix metalloproteinase. Guidebook to the extracellular matrix, anchor and adhesion proteins. Edited by: Kreis T, Vale R. 1999, Oxford University Press New York, 503-603.Google Scholar
- Brown LM, Fox HL, Hazen SA: Role of the matrixin MMP-2 in multicellular organization of adipocytes cultured in basement membrane components. Am J Physiol. 272 (3 Pt 1): C937-49.Google Scholar
- Bouloumié A, Sengenès C, Portolan G, et al: Adipocyte produces matrix metalloproteinases 2 and 9: involvement in adipose differentiation. Diabetes. 2001, 50: 2080-2086. 10.2337/diabetes.50.9.2080.PubMedView ArticleGoogle Scholar
- Lijnen HR: Plasmin and matrix metalloproteinases in vascular remodelling. Thrombosis and Haemostasis. 2001, 86: 324-333.PubMedGoogle Scholar
- Lijnen HR, Maquoi E, Demeulemeester D, et al: Modulation of fibrinolytic and gelatinolytic activity during adipose tissue development in a mouse model of nutritionally induced obesity. Thrombosis and Haemostasis. 2002, 88: 345-353.PubMedGoogle Scholar
- Lagente V, Boichot E: Matrix Metalloproteinases in Tissue Remodelling and Inflammation (Progress in Inflammation Research). 2008, 1-168.View ArticleGoogle Scholar
- Price SJ, Greaves DR, Watkins H: Identification of novel, functional genetic variants in the human matrix metalloproteinase-2 gene: role of Sp1 in allele-specific transcriptional regulation. J Biol Chem. 2001, 276: 7549-7558. 10.1074/jbc.M010242200.PubMedView ArticleGoogle Scholar
- Harendza S, Lovett DH, Panzer U, et al: Linked common polymorphisms in the gelatinase a promoter are associated with diminished transcriptional response to estrogen and genetic fitness. J Biol Chem. 2003, 278: 20490-20499. 10.1074/jbc.M211536200.PubMedView ArticleGoogle Scholar
- Vasku A, Goldbergova M, Izakovicova Holla L, et al: A haplotype constituted of four MMP-2 promoter polymorphisms (-1575G/A, -1306C/T, -790T/G and -735C/T) is associated with coronary triple-vessel disease. Matrix Biol. 2004, 22: 585-591. 10.1016/j.matbio.2003.10.004.PubMedView ArticleGoogle Scholar
- Thompson JM, Clark PM, Robinson E, et al: Risk factors for small-for-gestational-age babies: The Auckland Birthweight Collaborative Study. J Paediatr Child Health. 2001, 37 (4): 369-375. 10.1046/j.1440-1754.2001.00684.x.PubMedView ArticleGoogle Scholar
- Schaefer F, Georgi M, Zieger A, Schärer K: Usefulness of bioelectric impedance and skinfold measurements in predicting fat-free mass derived from total body potassium in children. Pediatr Res. 1994, 35 (5): 617-624.PubMedView ArticleGoogle Scholar
- Jurinke C, van der Boom D, Cantor CR, et al: The use of massARRAY technology for high throughput genotyping. Adv. Biochem. Eng. Biotechnol. 2002, 77: 57-74.PubMedGoogle Scholar
- Storm N, Darnhofer-Patel B, van der Boom D, et al: MALDI-TOF mass spectrometry-based SNP genotyping. Methods Molecular Biology. 2003, 212: 241-262.Google Scholar
- Balding DJ: A tutorial on statistical methods for population association studies. Nat Rev Genet. 2006, 7 (10): 781-791. 10.1038/nrg1916.PubMedView ArticleGoogle Scholar
- Cordell HJ, Clayton DG: Genetic association studies. Lancet. 2005, 366: 1121-1131. 10.1016/S0140-6736(05)67424-7.PubMedView ArticleGoogle Scholar
- Barrett JC, Fry B, Maller J, Daly MJ: Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005, 21 (2): 263-265. 10.1093/bioinformatics/bth457.PubMedView ArticleGoogle Scholar
- Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, et al: The structure of haplotype blocks in the human genome. Science. 2002, 296 (5576): 2225-2229. 10.1126/science.1069424.PubMedView ArticleGoogle Scholar
- Ihaka R, Gentleman R: R: A language for data analysis and graphics. Journal of Computational & Graphical Statistics. 1996, 5 (3): 299-314. 10.2307/1390807.Google Scholar
- Ober C, Leavitt SA, Tsalenko A, et al: Variation in the interleukin 4-receptor alpha gene confers susceptibility to asthma and atopy in ethnically diverse populations. Am J Hum Genet. 2000, 66: 517-526. 10.1086/302781.PubMedPubMed CentralView ArticleGoogle Scholar
- Bottini N, Borgiani P, Otsu A, et al: IL-4 receptor alpha chain genetic polymorphism and total IgE levels in the English population: two-locus haplotypes are more informative than individual SNPs. Clin Genet. 2002, 61: 288-292. 10.1034/j.1399-0004.2002.610408.x.PubMedView ArticleGoogle Scholar
- Han DH, Kim SK, Kang S, et al: Matrix Metallopeptidase 2 Gene Polymorphism is Associated with Obesity in Korean Population. Korean J Physiol Pharmacol. 2008, 12 (3): 125-129. 10.4196/kjpp.2008.12.3.125.PubMedPubMed CentralView ArticleGoogle Scholar
- Van Hul M, Lijnen HR: A functional role of gelatinase A in the development of nutritionally induced obesity in mice. J Thromb Haemost. 2008, 6 (7): 1198-206. 10.1111/j.1538-7836.2008.02988.x.PubMedView ArticleGoogle Scholar
- Glowinska-Olszewska B, Urban M, Florys B: Selected matrix metalloproteinases (MMP-2 and MMP-9) in obese children and adolescents. Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw. 2006, 12: 179-183.PubMedGoogle Scholar
- Glowinska-Olszewska B, Urban M: Elevated matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 in obese children and adolescents. Metabolism. 2007, 56: 799-805. 10.1016/j.metabol.2007.01.011.PubMedView ArticleGoogle Scholar
- Derosa G, Ferrari I, D'Angelo A, et al: Matrix metalloproteinase-2 and -9 levels in obese patients. Endothelium. 2008, 15 (4): 219-224. 10.1080/10623320802228815.PubMedView ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.